跳至主要内容
临床试验/NCT02737592
NCT02737592已完成不适用

A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects

Church & Dwight Company, Inc.2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2016年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
34
试验地点
2
主要终点
Number of Subjects With Observed Edema Based on the 5 Point Scoring Scale

研究概览

简要总结

To evaluate the safety of a personal lubricant when used at least four times weekly for two weeks (including at least twice weekly during sexual intercourse for subjects with monogamous male partners), in a population consisting of healthy females.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • no participation in a similar study 2-weeks prior
  • may be post-menopausal or have had a hysterectomy
  • if sexually active, and of child bearing potential, subjects is using adequate non-barrier method of birth control
  • free from any vaginal disorders
  • sexually active and in a monogamous, heterosexual relationship, and whose male partner is willing and able to give informed consent and agrees to engage in sexual intercourse at least twice each week during the two-week study or is not sexually active
  • personal lubricant user and agrees to replace her usual personal lubricant with the investigational product
  • can start regardless of where they are in their cycles
  • agrees to use the provided investigational product at least four time weekly over the two week study period
  • exhibits no clinically significant evidence of vulvar or vaginal irritation, as determined by a study doctor, and no reports of sensory irritation at the baseline exam
  • willing to refrain from introducing any new vaginal products, or using vaginal medications or local contraceptives during study
  • agrees to refrain from douching or using any medications, powder, lotions or personal care products in the vulvar or perianal area
  • willing to use a urine pregnancy test provided to them at baseline and on third visit
  • standard medical history form on file
  • signed informed consent
  • completed HIPAA
  • dependable and able to follow directions as outlined
  • receives a score of 0 or 0.5 for erythema and edema; and 0 for sensorial irritation (burning, stinging, itching and dryness) during the first examination.

排除标准

  • pregnant, nursing or planning a pregnancy
  • currently using or has used within two weeks prior to the study initiation, any systemic or topical corticosteroids, vasoconstrictors, antibiotics, anti-inflammatories or antihistamines
  • known allergies to vaginal or any cosmetic products
  • reports history of recurrent bladder, vaginal infections or incontinence
  • exhibits or reports gynecologic abnormalities or has had vaginitis within 60 days prior to study initiation
  • uses a vaginal ring, diaphram or cervical/vault caps, condoms, or condoms with spermicide as a means of contraception
  • participated in a study involving the vaginal area or in an investigational systemic drug study within two weeks of study initiation
  • receives a score higher than 0/5 for erythema, edema or >0 for burning, stinging, or itching, during first examination or shows any other sign of mucosal irregularities

结局指标

主要结局

Number of Subjects With Observed Edema Based on the 5 Point Scoring Scale

时间窗: 2 weeks

Number of subjects with observed local edema by OB/GYN examination as graded on 5 point clinical scale: 0 = normal appearance no edema, 0.5 = slight edema, 1 = mild edema, 2 = moderate edema 3 = severe edema

Number of Subjects With Observed Local Erythema Based on 5 Point Scale

时间窗: 2 weeks

Number of subjects with observed local erythema by OB/GYN examination as graded on 5 point clinical scale: 0 = normal appearance no irritation, 0.5 = slight, irregular erythema, 1 = mild erythema, 2 = moderate erythema 3 = severe erythema

次要结局

未报告次要终点

研究者

发起方
Church & Dwight Company, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验